Medicine Atlas

How Healing Is Practiced
Sign In
Text size
100%
Theme
Condition

Meningioma

Neoplasms

Meningioma, also known as meningeal tumor, is typically a slow-growing tumor that forms from the meninges, the membranous layers surrounding the brain and spinal cord; many cases remain asymptomatic, and symptoms when present depend on the tumor's location and result from pressure on nearby tissue. It occurs in about 1 per 1,000 people in the United States, usually in adults, affects women roughly twice as often as men, and is graded by the World Health Organization as grade 1, 2, or 3; risk factors include ionizing radiation and family history, and treatment ranges from observation to surgery and radiation therapy, with a 95 percent ten-year survival rate after complete removal.

Facts
Classification
Body SystemSourced to the subject's own account
Nervous System 1
ICD-10 Chapter
II: Neoplasms 2
Communicable or Non-communicable
Non-Communicable 3
Transmission Route
Non-Transmissible 3
First DescribedSourced to the subject's own account
1614 1
Sources
1. Meningioma (Wikipedia)
Wikipedia
  • Article text - era-first-described
    Meningiomas were reported as early as 1614 by Felix Plater.
  • Infobox: field
    Neurosurgery, Neuro-oncology
View the Source
2. Wikipedia: ICD-10
WikipediaList of chapters, Chapter II
Quote, List of chapters, Chapter II
Neoplasms
View the Source
3. World Health Organization: Noncommunicable diseases (fact sheet)
World Health Organization
  • Lead section, transmission-route statement (inferred from disease-category)
    The main types of NCDs are cardiovascular diseases (such as heart attacks and stroke), cancers, chronic respiratory diseases (such as chronic obstructive pulmonary disease and asthma) and diabetes.
  • Main Types section
    The main types of NCDs are cardiovascular diseases (such as heart attacks and stroke), cancers, chronic respiratory diseases (such as chronic obstructive pulmonary disease and asthma) and diabetes.
View the Source
Comments (0)
No comments yet. Be the first to share a thought.
Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.